Through this platform, resistance in bacterial samples can be tested within two hours compared to 24-27 hours through other ...

CrisprBits Develops PathCrisp for Early Detection of Antibiotic Resistance - Bengaluru, 20th: Bengaluru-based biotechnology ...

Antibiotic misuse, poor infection control, and high transmission rates of resistant pathogens fuel antimicrobial resistance and superbugs in hospitals.

Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical ...

Antimicrobial resistance (AMR) is a critical global health challenge, requiring early and accurate detection of resistance ...

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...